REG - Chrysalis Investment - Liquidity and Cash Update

Chrysalis InvestmentsAnnouncement

Yesterday 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260310:nRSJ9451Va&default-theme=true

RNS Number : 9451V  Chrysalis Investments Limited  10 March 2026

The information contained in this announcement is restricted and is not for
publication, release or distribution in the United States of America, any
member state of the European Economic Area (other than to professional
investors in Belgium, Denmark, the Republic of Ireland, Luxembourg, the
Netherlands, Norway and Sweden), Canada, Australia, Japan or the Republic of
South Africa.

 

The information contained within this announcement is deemed by the Company to
constitute inside information as stipulated under the Market Abuse Regulation
(EU) No. 596/2014 which forms part of domestic law in the United Kingdom
pursuant to The European Union Withdrawal Act 2018, as amended by The Market
Abuse (Amendment) (EU Exit) Regulations 2019.

 

 

10 March 2026

 

 

Chrysalis Investments Limited ("Chrysalis" or the "Company")

 

Liquidity and Cash Update

 

Liquidity Update

 

Further to the Company's announcement on 19 February 2026 regarding its
revised investment policy and its stated intention to repay the Barclays
facility in full at its September 2026 maturity, the Company provides the
following update.

 

Under the terms of the Company's existing financing facility with Barclays
Bank plc ("Barclays"), certain valuation movements in underlying portfolio
assets can affect the borrowing base used for loan-to-value calculations.
Following recent share price movements in Klarna, part of the Company's
borrowing base has reduced for the purposes of these calculations.

 

As a result, and in accordance with the facility terms, the Company has made a
repayment of £32.8 million to maintain compliance with the facility's
loan-to-value requirements. Given the Company's previously announced intention
to repay the facility in full in September 2026, this repayment represents a
partial prepayment of that amount and will correspondingly reduce the final
balance outstanding at maturity.

 

In addition, at the time of the origination of the facility, the Investment
Adviser negotiated the ability for the Company to repay up to £20 million
prior to the loan's maturity, free of any make-whole charges. The Company made
a prepayment of £10 million utilising this mechanism in October 2025 and has
utilised its capacity to repay a further £10 million, meaning a total of
£42.8 million has been repaid against the loan of £60 million, leaving
£17.2 million outstanding.

 

Cash Update

 

As of 6 March 2026, the Company had a total liquidity position of
approximately £76.7 million, following the above repayment, comprised of:

 

• Gross cash and cash equivalents of approximately £30.7 million, and

• Listed positions in Klarna and Wise of approximately £43.3 million and
£2.7 million respectively.

 

 

-ENDS-

 

 For further information, please contact:

 Media                                             +44 (0) 7921 881 800

 Montfort Communications:                          chrysalis@montfort.london

 Charlotte McMullen / Imogen Saunders

 Investment Adviser                                +44 (0) 20 7871 5343

 Chrysalis Investment Partners LLP:

 James Simpson

 AIFM                                              +44 (0) 20 7397 5450

 G10 Capital Limited:

 Dominic Williams

 Deutsche Numis:                                   +44 (0) 20 7260 1000

 Nathan Brown / Matt Goss

 Panmure Liberum:                                  +44 (0) 20 3100 2222

 Chris Clarke / Darren Vickers

 Barclays Bank PLC:                                +44 (0) 20 7623 2323

 Dion Di Miceli / Stuart Muress / James Atkinson

 IQEQ Fund Services (Guernsey) Limited:            +44 (0) 1481 231 852

 Aimee Gontier / Elaine Smeja

 

LEI: 213800F9SQ753JQHSW24

A copy of this announcement will be available on the Company's website at
https://www.chrysalisinvestments.co.uk
(https://www.chrysalisinvestments.co.uk)

The information contained in this announcement regarding the Company's
investments has been provided by the relevant underlying portfolio company and
has not been independently verified by the Company. The information contained
herein is unaudited.

This announcement is for information purposes only and is not an offer to
invest. All investments are subject to risk. Past performance is no guarantee
of future returns. Prospective investors are advised to seek expert legal,
financial, tax and other professional advice before making any investment
decision. The value of investments may fluctuate. Results achieved in the past
are no guarantee of future results. Neither the content of the Company's
website, nor the content on any website accessible from hyperlinks on its
website for any other website, is incorporated into, or forms part of, this
announcement nor, unless previously published by means of a recognised
information service, should any such content be relied upon in reaching a
decision as to whether or not to acquire, continue to hold, or dispose of,
securities in the Company.

The Company is an alternative investment fund ("AIF") for the purposes of the
AIFM Directive and as such is required to have an investment manager who is
duly authorised to undertake the role of an alternative investment fund
manager ("AIFM"). The AIFM appointed is G10 Capital Limited (part of the IQEQ
Group). Chrysalis Investment Partners LLP is the investment adviser to G10
Capital Limited. Chrysalis Investment Partners LLP (FRN: 1009684) is an
Appointed Representative of G10 Capital (FRN: 648953) Limited, which is
authorised and regulated by the Financial Conduct Authority.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCKKLFBQXLFBBQ



            Copyright 2019 Regulatory News Service, all rights reserved